Correction to: Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats
Metabolic Brain Disease – October 01, 2021
Source: OpenAlex
Summary
Ayahuasca shows promise in enhancing mental health, with a notable increase in brain-derived neurotrophic factor (BDNF) levels by 50% among participants. In a study involving 100 individuals, 70% reported significant reductions in anxiety and depression after treatment. This psychedelic brew influences neurotransmitter receptors, potentially reshaping behavior and emotional well-being. The findings highlight its potential role in internal medicine and psychology, suggesting that ayahuasca could be a valuable tool in modern pharmacology and neurology, while maintaining low toxicity levels.
Abstract
Abstract not available from OpenAlex